| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 616,205 | 506,516 | 388,776 | 548,712 | | Cost of Revenue | 461,589 | 404,129 | 340,737 | 451,088 | | | Gross Profit | 154,616 | 102,387 | 48,039 | 97,624 | | | Operating Expenses | | Research Development | 13,364 | 10,035 | 10,147 | 13,192 | | Selling General and Administrative | 53,619 | 52,445 | 50,068 | 58,399 | | Non Recurring |
-
|
-
|
-
| 671,117 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 87,779 | 39,907 | (12,176) | (645,084) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (9,213) | 1,928 | 21,005 | 52,993 | | Earnings Before Interest And Taxes | 984 | 41,835 | 8,829 | (592,091) | | Interest Expense | (49,158) | 30,638 | 27,707 | 27,677 | | Income Before Tax | 50,142 | 11,197 | (18,878) | (619,768) | | Income Tax Expense | (30,854) | 1,833 | 3,081 | 5,237 | | Minority Interest | (133) | (274) |
-
| 1,927 | | | | Net Income From Continuing Ops | 96,521 | 9,090 | (21,959) | (623,078) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 80,863 | 9,090 | (21,959) | (623,078) | | Preferred Stock And Other Adjustments |
-
| 133 | (133) |
-
| | | Net Income Applicable To Common Shares | $80,863 | $9,223 | ($22,092) | ($623,078) |
|
0.02% Nasdaq 
0.33%
Income Statement
